1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 2:

Aneurysm occlusion rate and outcomesa

CharacteristicPatients (n = 12)
Aneurysm occlusionb
 Complete obliteration8 (67%)
 Residual neck2 (16.5%)
 Residual aneurysm with contrast filling within the coils0
 Residual aneurysm with contrast filling between the coils and the aneurysm wall2 (16.5%)
Complications
 Ischemic complications2 (17%)
 Hemorrhagic complications1 (8%)
Symptomatic neurologic complications
 Permanent2 (17%)
 Transient0 (0%)
 Death1 (7.5%)
 Permanent symptomatic neurologic deficit or death3 (25%)
  • a All variables presented as No. (%).

  • b Median time to imaging follow-up 6.5 months (IQR, 6.2–6.8 months).